SYNGENE vs VIMTALABS: Stock Comparison

SYNGENE INTERNATIONAL vs VIMTA LABSUpdated 22 Sept 26, 4:08 PM ISTNSE & company filings

SYNGENE INTERNATIONAL is the larger company by market capitalisation. SYNGENE INTERNATIONAL shows a higher dividend yield and lower leverage, while VIMTA LABS shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SYNGENE leads 4; VIMTALABS leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SYNGENEVIMTALABS

Valuation lens

What price are you paying?

Market CapContext only
₹15,267 Cr
₹2,737 Cr
P/E RatioVIMTALABS has the lower reading
68.89x
0x
P/B RatioVIMTALABS has the lower reading
3.15x
0x
EPSVIMTALABS has the higher reading
₹-0.05
₹4.71
Book ValueContext only
₹119.88
₹102.28
Dividend YieldSYNGENE has the higher reading
0.34%
0.33%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SYNGENE is the larger company
₹15,267 Cr vs ₹2,737 Cr
P/E Ratio
VIMTALABS has a lower P/E
0x vs 68.89x
P/B Ratio
VIMTALABS has a lower P/B
0x vs 3.15x
EPS
VIMTALABS has higher earnings per share
₹4.71 vs ₹-0.05
Dividend Yield
SYNGENE has a higher dividend yield
0.34% vs 0.33%
Revenue Growth (TTM YoY)
VIMTALABS has faster revenue growth
16.5% vs 1.8%
EPS Growth (TTM YoY)
VIMTALABS has faster EPS growth
14.3% vs -19.5%
Qtr Sales Growth
SYNGENE has stronger quarterly sales growth
-9.92% vs -73.22%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSYNGENEVIMTALABS
SectorHealthcareHealthcare
IndustryHealthcare Research Analytics & TechnologyHealthcare Research Analytics & Technology

Price

MetricSYNGENEVIMTALABS
Live Price₹377.5₹610.15
Day Change-1.99%-0.96%
Volume4.22 L1.54 L
52-Week High₹678.95₹828.35
52-Week Low₹360.4₹376.05
Distance from 52W High-44.4%-26.34%

Valuation

MetricSYNGENEVIMTALABS
Market Cap₹15,267 Cr₹2,737 Cr
P/E Ratio68.89x0x
P/B Ratio3.15x0x
EPS₹-0.05₹4.71
Book Value₹119.88₹102.28
Dividend Yield0.34%0.33%

Growth

MetricSYNGENEVIMTALABS
Revenue Growth (TTM YoY)1.8%16.5%
EPS Growth (TTM YoY)-19.5%14.3%
Qtr Sales Growth-9.92%-73.22%
Qtr Profit Growth76.67%-72.85%

Profitability & Leverage

MetricSYNGENEVIMTALABS
ROE6.54%16.97%
ROCE7.51%17.48%
Net Margin11.26%19.03%
Operating Margin12.3%25.81%
Debt to Equity0x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSYNGENEVIMTALABS
Promoter Holding52.59% 0.09 pp35.67% 0.18 pp
FII Holding11.82% 2.08 pp4.42% 0.47 pp
DII Holding28.02% 1.58 pp0.37% 0.23 pp
Public Holding7.14% 0.45 pp59.55% 0.43 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SYNGENE INTERNATIONAL and VIMTA LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.